22 results
Medical Treatment Algorithm for Chronic Obstructive Pulmonary Disease
Initial medical treatment of chronic obstructive pulmonary disease (COPD)
Algorithm for Chronic ... corticosteroid; LABA ... #Algorithm #Management ... #Pulmonary #LABA ... #ICS #Pharmacology
Pharmacologic treatment algorithms by Global Initiative for Chronic Obstructive Lung Disease grade. Highlighted boxes and arrows
Pharmacologic treatment ... algorithms by Global ... indicate preferred treatment ... #Management #Pulmonary ... #LABA #ICS #Guidelines
Summary of Recommendations for the Treatment of Aspergillosis - IDSA Guidelines
 - Invasive syndromes of Aspergillus
Aspergillosis - IDSA ... Aspergillosis #Treatment ... #pharmacology # ... dosing #medications ... #IDSA #Guidelines
IDSA Aspergillosis Treatment
 • Invasive pulmonary aspergillosis (IPA)
 • CNS aspergillosis
 • Cardiac Aspergillus infection
 •
IDSA Aspergillosis ... Treatment • Invasive ... pulmonary aspergillosis ... #management #pharmacology ... #IDSA
The 2019 Global Initiative for Asthma (GINA) treatment strategy figure for adults and adolescents, annotated to
Asthma (GINA) treatment ... receptor antagonists; LABA ... Management #Stepwise #Pulmonary ... #StepUp #Treatment ... #Algorithm #Guidelines
IDSA - Doses of Drugs for Treatment of Adults and Children with Multidrug-Resistant Tuberculosis
Step 1 Levofloxacin,
IDSA - Doses of ... Drugs for Treatment ... MDRTB #management #Treatment ... antimicrobials #pharmacology ... #dosing #idsa #
Prostanoid prescribing and management in Pulmonary Arterial Hypertension (PAH)
Oral Prostanoids:
 - Selexipag
 - Treprostinil
Inhaled Prostanoids
 -
management in Pulmonary ... #prescribing #Pulmonary ... PAH #Management #Algorithm ... #treatment #pharmacology
LABA/ICS Combination Inhalers
Long-Acting Beta2 Agonists (LABA) + Inhaled Corticosteroid (ICS) - Commonly used in Asthma 
Advair
LABA/ICS Combination ... posts for the COPD treatment ... algorithm). ... are the normal dosing ... Naming #Names #Pharmacology
Daliresp (Roflumilast) 
Indication: Reduce risk of COPD exacerbations 
Drug Class: Selective Phosphodiesterase-4 (PDE4) Inhibitor 
GOLD 2019
/LABA/ICS) - ... /LABA) & Eosinophils ... < 100 Dosing: ... recommendations for the treatment ... #Indications #Pharmacology
RIPE Therapy - Drug Regimens for Microbiologically Confirmed Pulmonary Tuberculosis - IDSA Guidelines

#Tuberculosis #ActiveTB #RIPE #Therapy
Microbiologically Confirmed Pulmonary ... Tuberculosis - IDSA ... #medications #pharmacology ... #IDSA #Guidelines ... #Treatment